Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Vivo Capital Surplus Fund Viii, L.p.
Relationship:   10% Owner
City:   Palo Alto,
State:   CA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   0    

Indirect Shares

  1,277,864      
Direct Value   $0    

Indirect Value

  $16,331,885      
Total Shares   1,277,864      
Total Value   $16,331,885      


                                          Charting Not Avaliable
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

      
       
     Stock price went down :
      
       
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Crinetics Pharmaceuticals, Inc. CRNX 10% Owner 2020-04-03 0 2020-04-17 298,625    Premium*  
            Aligos Therapeutics, Inc. ALGS 10% Owner 2020-10-20 0 2020-10-20 430,372    Premium*  
            Impel Neuropharma Inc IMPL 10% Owner 2021-04-27 0 2023-12-19 280,294    Premium*  
            Terns Pharmaceuticals, Inc. TERN 10% Owner 2022-08-12 0 2024-04-03 268,573    Premium*  
* Premium Members only  

Records found :    19         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
TERN Terns Pharmaceuticals, In... 10% Owner   –       –       •   2024-04-03 4 AS $6.20 $856,009 I/I (138,066) 268,573 0 %
TERN Terns Pharmaceuticals, In... 10% Owner   –       –       •   2024-04-02 4 AS $6.65 $674,842 I/I (101,480) 272,722 0 %
TERN Terns Pharmaceuticals, In... 10% Owner   –       –       •   2024-04-01 4 AS $6.99 $1,266,008 I/I (181,117) 275,772 0 %
IMPL Impel Neuropharma Inc 10% Owner   –       –       •   2023-12-19 4 S $0.08 $18,983 I/I (237,289) 280,294 0 -
IMPL Impel Neuropharma Inc 10% Owner   –       –       •   2023-12-18 4 S $0.11 $26,148 I/I (237,711) 308,926 0 -
IMPL Impel Neuropharma Inc 10% Owner   –       –       •   2023-12-15 4 S $0.29 $29,000 I/I (100,000) 337,608 0 -
TERN Terns Pharmaceuticals, In... 10% Owner   –       –       •   2022-09-07 4 B $3.60 $2,160,000 I/I 600,000 3,581,592 1.5 %
TERN Terns Pharmaceuticals, In... 10% Owner   –       –       •   2022-08-16 4 B $2.42 $3,630,000 I/I 1,500,000 2,981,592 1.5 %
TERN Terns Pharmaceuticals, In... 10% Owner   –       –       •   2022-08-15 4 B $2.99 $3,642 I/I 1,218 1,481,592 1.42 %
TERN Terns Pharmaceuticals, In... 10% Owner   –       –       •   2022-08-12 4 B $2.98 $3,346,603 I/I 1,123,021 1,480,374 1.5 %
IMPL Impel Neuropharma Inc 10% Owner   –       –       •   2021-04-27 4 B $15.00 $8,625,000 I/I 575,000 349,674 1.5 -
IMPL Impel Neuropharma Inc 10% Owner   –       –       •   2021-04-27 4 A $0.00 $1,369,656 I/I 2,309,789 280,294 0 -
ALGS Aligos Therapeutics, Inc. 10% Owner   –       –       •   2020-10-20 4 B $15.00 $8,250,000 I/I 550,000 430,372 1.5 -
ALGS Aligos Therapeutics, Inc. 10% Owner   –       –       •   2020-10-20 4 A $0.00 $0 I/I 2,997,030 363,639 0 -
CRNX Crinetics Pharmaceuticals... 10% Owner   –       –       •   2020-04-17 4 S $15.40 $1,302,809 I/I (84,598) 298,625 0 %
CRNX Crinetics Pharmaceuticals... 10% Owner   –       –       •   2020-04-16 4 S $15.20 $458,888 I/I (30,190) 308,890 0 %
CRNX Crinetics Pharmaceuticals... 10% Owner   –       –       •   2020-04-15 4 S $15.50 $3,345,055 I/I (215,810) 312,553 0 %
CRNX Crinetics Pharmaceuticals... 10% Owner   –       –       •   2020-04-07 4 S $14.20 $86,833 I/I (6,115) 338,738 0 %
CRNX Crinetics Pharmaceuticals... 10% Owner   –       –       •   2020-04-03 4 S $13.80 $4,140,000 I/I (300,000) 339,480 0 %

  19  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed